Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $10.00 at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its price target boosted by Truist Financial from $9.50 to $10.00 in a research report report published on Friday morning,Benzinga reports. They currently have a hold rating on the stock.

AVAH has been the topic of several other research reports. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Raymond James Financial upgraded shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a research note on Monday, August 11th. JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and increased their target price for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Jefferies Financial Group boosted their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $10.07.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH traded up $0.12 during trading on Friday, reaching $8.75. The stock had a trading volume of 1,381,278 shares, compared to its average volume of 1,771,923. The stock has a market cap of $1.83 billion, a PE ratio of 24.31 and a beta of 2.04. Aveanna Healthcare has a one year low of $3.67 and a one year high of $10.32. The firm’s 50 day moving average price is $8.86 and its two-hundred day moving average price is $6.48.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 103.46%. The firm had revenue of $450.53 million for the quarter. On average, research analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the sale, the insider owned 20,544,696 shares in the company, valued at $184,902,264. The trade was a 28.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the completion of the transaction, the insider directly owned 386,284 shares of the company’s stock, valued at $3,476,556. This represents a 96.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,597,968 shares of company stock valued at $293,381,712 over the last ninety days. Corporate insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare in the 1st quarter worth about $25,000. Quantbot Technologies LP purchased a new stake in shares of Aveanna Healthcare in the second quarter worth approximately $43,000. Jump Financial LLC purchased a new stake in shares of Aveanna Healthcare in the first quarter worth approximately $59,000. Diversified Trust Co acquired a new stake in shares of Aveanna Healthcare during the second quarter worth approximately $57,000. Finally, MQS Management LLC purchased a new position in Aveanna Healthcare during the second quarter valued at approximately $59,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.